Cholangiocarcinomas Completed Phase 2 Trials for Varlitinib (DB05944)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02609958ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic TherapyTreatment